CBC & Mubadala in Neurology and Allergy Play
27 Aug 2024
US$ 19.00
CBC Group and Mubadala Investment Co have agreed to buy the neurology and allergy business in China from UCB SA ......
Related Publications
Legend Capital made a follow-on investment in the pre-series A funding round of Dipeak Technology, a provider of...
Listen to Subscribers' Weekly 31 Oct 2025...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.